Clinical Trial Update: Effect of Dual Bronchodilation With Umeclidinium/Vilanterol on Patients With COPD, Hyperinflation and Heart Failure [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating dual bronchodilation with umeclidinium/vilanterol in COPD patients with hyperinflation and heart failure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease
• Heart Failure

Drugs mentioned

• Umeclidinium/Vilanterol (umeclidinium/vilanterol)

Snippet

Sponsor: Luis Puente Maestu | Conditions: Copd, Heart Failure | Phase 4 | Status: UNKNOWN